Quadrature Capital LTD Inmune Bio, Inc. Transaction History
Quadrature Capital LTD
- $4.51 Trillion
- Q1 2025
A detailed history of Quadrature Capital LTD transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Quadrature Capital LTD holds 12,301 shares of INMB stock, worth $90,781. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,301Holding current value
$90,781% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding INMB
# of Institutions
91Shares Held
6.87MCall Options Held
202KPut Options Held
104K-
Praetorian Pr LLC Rincon, PR865KShares$6.38 Million2.92% of portfolio
-
Vanguard Group Inc Valley Forge, PA827KShares$6.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY813KShares$6 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$4.4 Million45.87% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL382KShares$2.82 Million0.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $132M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...